These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 1139073

  • 21. Effects of 2-bromo-alpha-ergocryptine and pimozide on growth hormone secretion in man.
    Dammacco F, Rigillo N, Tafaro E, Gagliardi F, Chetri G, Dammacco A.
    Horm Metab Res; 1976 May; 8(3):247-8. PubMed ID: 939473
    [No Abstract] [Full Text] [Related]

  • 22. Release of brain dopamine as the probable mechanism for the hypothermic effect of D-amphetamine.
    Yehuda S, Wurtman RJ.
    Nature; 1972 Dec 22; 240(5382):477-8. PubMed ID: 4565945
    [No Abstract] [Full Text] [Related]

  • 23. Stereotyped responses of rats to two 2-halogenoergolines: 2-bromo-alpha-ergocryptine and lergotrile.
    Bergmann F.
    Isr J Med Sci; 1982 Jan 22; 18(1):177-82. PubMed ID: 6121772
    [Abstract] [Full Text] [Related]

  • 24. Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas.
    Arnerić SP, Chow SA, Long JP, Fischer LJ.
    J Pharmacol Exp Ther; 1984 Mar 22; 228(3):551-9. PubMed ID: 6142939
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Bromocriptine inhibits 2-deoxy-D-glucose-stimulated gastric acid secretion in the rat.
    Maeda-Hagiwara M, Watanabe K.
    Eur J Pharmacol; 1983 May 20; 90(1):11-7. PubMed ID: 6873172
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Is acetylcholine involved in a dopamine receptor mediated hypothermia in mice and rats?
    Cox B, Lee TF.
    Br J Pharmacol; 1978 Mar 20; 62(3):339-47. PubMed ID: 638313
    [Abstract] [Full Text] [Related]

  • 30. Effects of bromocriptine on central dopaminergic receptors.
    Trabucchi M, Spano PF, Tonon GC, Frattola L.
    Life Sci; 1976 Jul 15; 19(2):225-31. PubMed ID: 183071
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Substituted ergolines: potential antipsychotics with unique profile. I. Psychopharmacological characterization.
    Groó D, Palosi A.
    Pol J Pharmacol Pharm; 1988 Jul 15; 40(6):593-601. PubMed ID: 2908363
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of pimozide on the increase of muscarinic receptors caused by mazindol and apomorphine in the rat cerebral motor cortex.
    de-Sousa FC, Marinho MM, Aguiar GV, Viana GS.
    Braz J Med Biol Res; 1995 Jan 15; 28(1):113-9. PubMed ID: 7581019
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.